Somatostatin Receptor Type Market Overview by Recent Opportunities, Growth Size, Regional Analysis and Forecasts to 2027
The global somatostatin receptor type market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Somatostatin is a hormone that regulates a wide variety of physiological functions and is produced by numerous tissues in the body mostly in the nervous and digestive systems. Additionally, it inhibits the secretion of other hormones such as the activity of the gastrointestinal tract and the rapid reproduction of normal and tumour cells. The major factor driving the demand for somatostatin receptor type is the increasing prevalence of cancer across the globe.
According to the National Cancer Institute (NCI), it was
estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a
mortality rate of 606,520 people in 2020. In men, prostate, lung, and
colorectal cancers will account for an estimated 43% of all cancers diagnosed
while for women, the three most common cancers are breast, lung, and colorectal
which will account for an estimated 50% of all new cancer diagnoses in women in
2020. Furthermore, there were 18.1 million new cases and 9.5 million
cancer-related mortalities globally in 2018 which is anticipated to rise to
29.5 million and the number of cancer-related mortalities to 16.4 million by
2040. Hence, the increasing prevalence of cancer is driving the demand for
somatostatin receptor types as their activation results in inhibition of cell
proliferation.
To Request a Sample of our Report on Somatostatin
Receptor Type Market: https://www.omrglobal.com/request-sample/somatostatin-receptor-type-market
Some major players in the market include Merck KGaA, and
Chiasma, Inc., among others. The market players are contributing significantly
to the growth of the market by the adoption of various strategies including
mergers & acquisitions, geographical expansion, partnerships and
collaborations, and new product launches, to stay competitive in the market.
For instance, in June 2020, Chiasma, Inc. announced the approval of MYCAPSSA
(octreotide) capsules by the U.S. Food and Drug Administration (FDA). It is an oral
somatostatin analog (SSA) used for the long-term maintenance treatment in
acromegaly patients who have responded to and tolerated treatment with
octreotide or lanreotide.
Market Coverage
• The
market number available for – 2020-2027
• Base
year- 2020
• Forecast
period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape-
Merck KGaA, and Chiasma, Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of Somatostatin Receptor Type Market is Available @ https://www.omrglobal.com/industry-reports/somatostatin-receptor-type-market
Global Somatostatin Receptor Type Market Report by
Segment
By Type
• sstr1
• sstr2A
• sstr2B
• sstr3
• sstr4
• sstr5
By Application
• Alzheimer's
Disease
• Cancer
• Hormonal
Disorder
• Others
Global Somatostatin Receptor Type Market Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment